Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Malcolm L. Meeson"'
Autor:
Dashyant Dhanak, Malcolm L. Meeson, Richard L. Elliott, Deirdre M. B. Hickey, Andrew D. Shore, R. Curtis Haltiwanger
Publikováno v:
Synthetic Communications. 31:2713-2718
A mild, base mediated conversion of an azetidin-2-one to the [1,4]-diazapinedione system is reported and a putative mechanistic pathway is proposed.
Autor:
Andrew D. Shore, Deirdre M. B. Hickey, Dashyant Dhanak, Richard L. Elliott, R. Curtis Haltiwanger, Malcolm L. Meeson
Publikováno v:
ChemInform. 32
A mild, base mediated conversion of an azetidin-2-one to the [1,4]-diazapinedione system is reported and a putative mechanistic pathway is proposed.
Autor:
Leach Colin Andrew, David R. Reavill, Kenneth Wiggall, Colin J. Theobald, David J. Keeling, Robert John Ife, Thomas Henry Brown, Malcolm L. Meeson, Michael E. Parsons
Publikováno v:
Journal of Medicinal Chemistry. 35:3413-3422
Previously, gastric (H+/K+)-ATPase inhibitors such as 2 have been prepared as analogues of 1a on the presumption that the 3-carbethoxy substituent plays a key role in establishing the orientation of the 4-arylamino group. In this paper we explore fur
Autor:
Emma K. Dodds, Jayneeta Gohil, Robert John Ife, Ian Thomson Forbes, Pieter H. E. Groot, Kitty Moores, Theo A. Berkhout, Deirdre M. B. Hickey, David Gwyn Cooper, Martin Stockley, Malcolm L. Meeson
Publikováno v:
Bioorganicmedicinal chemistry letters. 10(16)
A weak HTS hit at the CCR2B receptor has been converted into a potent antagonist by array SAR studies. Selectivity over the closely related CCR5 receptor is also achieved.
Autor:
Leach Colin Andrew, David J. Keeling, Colin J. Theobald, Malcolm L. Meeson, Robert John Ife, Michael E. Parsons, Peter Blurton, Thomas Henry Brown
Publikováno v:
Journal of medicinal chemistry. 38(14)
Quinazolines bearing a secondary 4-(arylamino) substituent demonstrate an SAR for inhibition of the gastric (H + /K + )-ATPase different from the previously described 3-acylquinolines, suggesting that, although these compounds are also K + -competiti
Autor:
Michael E. Parsons, Carol A. Harvey, C. Robin Ganellin, Malcolm L. Meeson, Brian Peter Slingsby, Robert John Ife, Keith W Catchpole, Graham J. Durant, Colin J. Theobald, David A. A. Owen
Publikováno v:
European Journal of Medicinal Chemistry. 24:249-257
Using the combined H 1 /H 2 -receptor histamine antagonist, icotidine (SK&F 93319, 5b ) as a starting point, a series of pyridylaminoalkylaminopyrimidones has been evaluated as potential selective H 1 -receptor antagonists with low ability to penetra
Autor:
Robert John Ife, Catherine A. Dyke, Eugene Meenan, David J. Keeling, Anthony H. Underwood, Colin J. Theobald, Carolyn A. Price, Michael E. Parsons, Malcolm L. Meeson
Publikováno v:
Journal of Medicinal Chemistry. 32:1970-1977
The benzimidazole sulfoxide class of antisecretory H+/K+-ATPase inhibitors need to possess high stability under neutral physiological conditions yet rearrange rapidly at low pH to the active sulfenamide 2. Since the initial reaction involves internal
Autor:
Charon Robin Ganellin, Brian Peter Slingsby, D. A. A. Owen, Graham J. Durant, Malcolm L. Meeson, Robert J. Ife, C. J. Theobald, Michael E. Parsons, K. W. Catchpole, C. A. Harvey
Publikováno v:
ChemInform. 20